CONNECT BIOPHARMA HOLDINGS L (CNTB) Stock Balance Sheet
NASDAQ:CNTB - Nasdaq - US2075231017 - ADR - Currency: USD
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 10.77M | 353.40M | 1.65B | 975.80M | 303.10M | |||
| Cash Equivalents | 95.24M | 196.90M | 60.90M | 34.30M | 5.90M | |||
| Marketable Securities | 12.65M | 511.30M | 0.00 | 13.10M | 30.60M | |||
| Receivables | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 2.32M | 23.40M | 47.20M | 33.60M | 23.30M | |||
| Total Current Assets | 120.97M | 1.08B | 1.75B | 1.06B | 362.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.73M | 59.00M | 82.20M | 7.90M | 3.40M | |||
| Investments And Advances | 0.00 | 65.70M | N/A | N/A | N/A | |||
| Intangibles | 62.00K | 500.00K | 600.00K | 300.00K | 0.00 | |||
| Other Non-Current Assets | 24.00K | 600.00K | 800.00K | 9.60M | 0.00 | |||
| Total Non-Current Assets | 4.92M | 127.00M | 101.60M | 28.10M | 9.80M | |||
| TOTAL ASSETS | 125.89M | 1.21B | 1.86B | 1.08B | 372.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 285.00K | 1.30M | 600.00K | 600.00K | 400.00K | |||
| Accrued Expenses | 2.56M | 20.70M | 13.70M | 12.20M | 4.00M | |||
| Accounts Payable | 7.66M | 83.10M | 81.20M | 24.60M | 22.80M | |||
| Other Current Liabilities | 13.76M | 3.70M | 19.10M | 500.00K | 200.00K | |||
| Total Current Liabilities | 24.26M | 108.80M | 114.70M | 38.00M | 27.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 180.00K | 1.70M | 200.00K | 2.07B | 643.50M | |||
| Other Non-Current Liabilities | 405.00K | 4.50M | 5.00M | N/A | N/A | |||
| Total Non-Current Liabilities | 585.00K | 6.30M | 5.10M | 2.07B | 643.50M | |||
| TOTAL LIABILITIES | 24.85M | 115.10M | 119.80M | 2.11B | 670.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -519.62M | -3.07B | -2.32B | -1.06B | -287.70M | |||
| Additional Paid In Capital | 628.71M | 4.09B | 4.09B | 41.50M | 38.10M | |||
| Common Shares | 10.00K | 100.00K | 100.00K | 0.00 | 0.00 | |||
| Treasury Stock | -180.00K | -1.20M | -1.20M | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -7.88M | 71.10M | -41.20M | -1.70M | -48.70M | |||
| Shares Outstanding | 57.20M | 57.09M | 57.19M | 55.50M | 55.50M | |||
| Tangible Book Value per Share | 1.76 | 19.10 | 30.18 | -18.37 | -5.35 | |||
| Total Shareholders' Equity | 101.04M | 1.10B | 1.74B | -1.02B | -298.30M | |||
| TOTAL LIABILITIES AND EQUITY | 125.89M | 1.21B | 1.86B | 1.08B | 372.60M | |||
| Statistics | ||||||||
| Debt/Equity | 0.00 | 0.00 | 0.00 | -2.02 | -2.16 | |||
| Current Ratio | 4.99 | 9.97 | 15.29 | 27.81 | 13.24 | |||
| Return On Assets (ROA) | -47.27% | -65.77% | -70.42% | -71.83% | -45.26% | |||
| Return On Equity (ROE) | -58.89% | -72.66% | -75.29% | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21